ORBIMED CAPITAL GP II LLC's Net Worth

$32.3 Million

Estimate Recalculated Apr 25, 2024 03:10PM EST

Who is ORBIMED CAPITAL GP II LLC?

ORBIMED CAPITAL GP II LLC has an estimated net worth of $32.3 Million. This is based on reported shares across multiple companies, which include INSULET CORP, Volcano Corp, SUPERNUS PHARMACEUTICALS INC, AVANIR PHARMACEUTICALS, ACCELERON PHARMA INC, CRYOCOR INC, and GIVEN IMAGING LTD.

SEC CIK

ORBIMED CAPITAL GP II LLC's CIK is 0001281668

Past Insider Trading and Trends

2013 was ORBIMED CAPITAL GP II LLC's most active year for acquiring shares with 12 total transactions. ORBIMED CAPITAL GP II LLC's most active month to acquire stocks was the month of August. 2013 was ORBIMED CAPITAL GP II LLC's most active year for disposing of shares, totalling 16 transactions. ORBIMED CAPITAL GP II LLC's most active month to dispose stocks was the month of August. 2012 saw ORBIMED CAPITAL GP II LLC paying a total of $5,500,000.00 for 3,599,998 shares, this is the most they've acquired in one year. In 2006 ORBIMED CAPITAL GP II LLC cashed out on 3,880,396 shares for a total of $12,726,339.18, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INSULET CORP (PODD) Snapshot price: $199.08

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Volcano Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.37M
—
—
2.37M
Jun 20
Form 3
—
0
—
—
0
No matching records found

SUPERNUS PHARMACEUTICALS INC (SUPN) Snapshot price: $27.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-4.68%
-302.18K
$7.55
-$2,281,045.09
6.15M
Feb 12 - Feb 13
Form 4
-100.00%
-297.81K
$6.92
-$2,062,287.34
0
Dec 17 - Dec 18
Form 4
+144.00%
3.6M
$5.00
$5,500,000.00
6.1M
May 4
Form 3
—
0
—
—
0
No matching records found

AVANIR PHARMACEUTICALS No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
-26.94%
-629.12K
$9.79
-$6,159,094.59
1.71M
May 31
Form 4
-26.94%
-629.12K
$9.79
-$6,159,094.59
1.71M
May 31
Form 4
∞
2.34M
—
—
2.34M
Feb 13
Form 3
—
0
—
—
0
No matching records found

ACCELERON PHARMA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+22.75%
2.11M
—
—
11.38M
Sep 24
Form 3
—
0
—
—
0
No matching records found